"Mupirocin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.
| Descriptor ID |
D016712
|
| MeSH Number(s) |
D02.355.291.411.658 D03.383.663.555 D10.251.536
|
| Concept/Terms |
Mupirocin- Mupirocin
- Pseudomonic Acid A
- Pseudomonic Acid
- Acid, Pseudomonic
|
Below are MeSH descriptors whose meaning is more general than "Mupirocin".
Below are MeSH descriptors whose meaning is more specific than "Mupirocin".
This graph shows the total number of publications written about "Mupirocin" by people in this website by year, and whether "Mupirocin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mupirocin" by people in Profiles.
-
Synthesis and Evaluation of Polyethylene Glycol-4000-Co-Poly (AMPS) Based Hydrogel Membranes for Controlled Release of Mupirocin for Efficient Wound Healing. Curr Drug Deliv. 2022; 19(10):1102-1115.
-
Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes database. Pediatr Dermatol. 2021 Jan; 38(1):119-124.
-
Clinical and Molecular Features of Decreased Chlorhexidine Susceptibility among Nosocomial Staphylococcus aureus Isolates at Texas Children's Hospital. Antimicrob Agents Chemother. 2016 Feb; 60(2):1121-8.
-
Decreased susceptibilities to Retapamulin, Mupirocin, and Chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children. Antimicrob Agents Chemother. 2014 May; 58(5):2878-83.
-
Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children. Antimicrob Agents Chemother. 2011 May; 55(5):2431-3.
-
Decrease in Staphylococcus aureus colonization and hospital-acquired infection in a medical intensive care unit after institution of an active surveillance and decolonization program. Infect Control Hosp Epidemiol. 2010 Aug; 31(8):779-83.
-
Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children. Clin J Am Soc Nephrol. 2009 Dec; 4(12):1939-43.
-
Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and S?zary syndrome. Br J Dermatol. 2008 Jul; 159(1):105-12.
-
Intranasal mupirocin to prevent postoperative infections. N Engl J Med. 2002 Oct 10; 347(15):1207-8; author reply 1207-8.
-
Cost-effectiveness of erythromycin versus mupirocin for the treatment of impetigo in children. Pediatrics. 1992 Feb; 89(2):210-4.